Literature DB >> 12489913

Is dementia with Lewy bodies the second most common cause of dementia?

Judith L Heidebrink1.   

Abstract

Lewy bodies were originally described in isolated brainstem nuclei in persons with Parkinson's disease. They have since been recognized as a widespread and common neuropathologic finding in individuals with dementia. Dementia with Lewy bodies (DLB) is the preferred term for the dementia syndrome associated with Lewy bodies. Although DLB is acknowledged as the second most common degenerative dementia, trailing only Alzheimer's disease, its ranking with respect to vascular dementia remains controversial. Large, community-based studies of DLB with postmortem confirmation are lacking. Available data suggest that DLB is more common than pure vascular dementia but not more common than any vascular contribution to dementia.

Entities:  

Mesh:

Year:  2002        PMID: 12489913     DOI: 10.1177/089198870201500402

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  19 in total

Review 1.  Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.

Authors:  Jenny McCleery; Shirlony Morgan; Kevin M Bradley; Anna H Noel-Storr; Olaf Ansorge; Chris Hyde
Journal:  Cochrane Database Syst Rev       Date:  2015-01-30

Review 2.  Sleep, Cognition and Dementia.

Authors:  Verna R Porter; William G Buxton; Alon Y Avidan
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

3.  MicroRNA expression patterns in human anterior cingulate and motor cortex: A study of dementia with Lewy bodies cases and controls.

Authors:  Peter T Nelson; Wang-Xia Wang; Sarah A Janse; Katherine L Thompson
Journal:  Brain Res       Date:  2017-11-13       Impact factor: 3.252

Review 4.  Cognition, language, and clinical pathological features of non-Alzheimer's dementias: an overview.

Authors:  Jamie Reilly; Amy D Rodriguez; Martine Lamy; Jean Neils-Strunjas
Journal:  J Commun Disord       Date:  2010-05-06       Impact factor: 2.288

Review 5.  MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.

Authors:  Catherine Labbé; Michael G Heckman; Oswaldo Lorenzo-Betancor; Alexandra I Soto-Ortolaza; Ronald L Walton; Melissa E Murray; Mariet Allen; Ryan J Uitti; Zbigniew K Wszolek; Glenn E Smith; Kejal Kantarci; David S Knopman; Val J Lowe; Clifford R Jack; Nilüfer Ertekin-Taner; Anhar Hassan; Rodolfo Savica; Ronald C Petersen; Joseph E Parisi; Demetrius M Maraganore; Neill R Graff-Radford; Tanis J Ferman; Bradley F Boeve; Dennis W Dickson; Owen A Ross
Journal:  Alzheimers Dement       Date:  2016-06-07       Impact factor: 21.566

6.  Comparison of clinical manifestations in Alzheimer disease and dementia with Lewy bodies.

Authors:  Angela Nervi; Christiane Reitz; Ming-Xin Tang; Vincent Santana; Angel Piriz; Dolly Reyes-Dumeyer; Rafael Lantigua; Martin Medrano; Ivonne Z Jiménez-Velázquez; Joseph H Lee; Richard Mayeux
Journal:  Arch Neurol       Date:  2008-12

7.  Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB.

Authors:  Peter T Nelson; Richard J Kryscio; Erin L Abner; Frederick A Schmitt; Gregory A Jicha; Marta S Mendiondo; Greg Cooper; Charles B Smith; William R Markesbery
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

8.  Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies.

Authors:  Daniel Erskine; Jinhui Ding; Alan J Thomas; Alice Kaganovich; Ahmad A Khundakar; Peter S Hanson; John-Paul Taylor; Ian G McKeith; Johannes Attems; Mark R Cookson; Christopher M Morris
Journal:  Mov Disord       Date:  2018-03-23       Impact factor: 10.338

9.  Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies.

Authors:  Celia Kun-Rodrigues; Owen A Ross; Tatiana Orme; Claire Shepherd; Laura Parkkinen; Lee Darwent; Dena Hernandez; Olaf Ansorge; Lorraine N Clark; Lawrence S Honig; Karen Marder; Afina Lemstra; Philippe Scheltens; Wiesje van der Flier; Eva Louwersheimer; Henne Holstege; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Imelda Barber; Anne Braae; Kristelle Brown; Kevin Morgan; Walter Maetzler; Daniela Berg; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Janice Holton; Yaroslau Compta; Vivianna Van Deerlin; John Q Trojanowski; Geidy E Serrano; Thomas G Beach; Jordi Clarimon; Alberto Lleó; Estrella Morenas-Rodríguez; Suzanne Lesage; Douglas Galasko; Eliezer Masliah; Isabel Santana; Monica Diez; Pau Pastor; Pentti J Tienari; Liisa Myllykangas; Minna Oinas; Tamas Revesz; Andrew Lees; Brad F Boeve; Ronald C Petersen; Tanis J Ferman; Valentina Escott-Price; Neill Graff-Radford; Nigel J Cairns; John C Morris; David J Stone; Stuart Pickering-Brown; David Mann; Dennis W Dickson; Glenda M Halliday; Andrew Singleton; Rita Guerreiro; Jose Bras
Journal:  Neurobiol Aging       Date:  2016-09-02       Impact factor: 4.673

10.  A comprehensive screening of copy number variability in dementia with Lewy bodies.

Authors:  Celia Kun-Rodrigues; Tatiana Orme; Susana Carmona; Dena G Hernandez; Owen A Ross; John D Eicher; Claire Shepherd; Laura Parkkinen; Lee Darwent; Michael G Heckman; Sonja W Scholz; Juan C Troncoso; Olga Pletnikova; Ted Dawson; Liana Rosenthal; Olaf Ansorge; Jordi Clarimon; Alberto Lleo; Estrella Morenas-Rodriguez; Lorraine Clark; Lawrence S Honig; Karen Marder; Afina Lemstra; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Imelda Barber; Anne Braae; Kristelle Brown; Kevin Morgan; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Janice Holton; Yaroslau Compta; Vivianna Van Deerlin; Geidy E Serrano; Thomas G Beach; Suzanne Lesage; Douglas Galasko; Eliezer Masliah; Isabel Santana; Pau Pastor; Monica Diez-Fairen; Miquel Aguilar; Pentti J Tienari; Liisa Myllykangas; Minna Oinas; Tamas Revesz; Andrew Lees; Brad F Boeve; Ronald C Petersen; Tanis J Ferman; Valentina Escott-Price; Neill Graff-Radford; Nigel J Cairns; John C Morris; Stuart Pickering-Brown; David Mann; Glenda M Halliday; John Hardy; John Q Trojanowski; Dennis W Dickson; Andrew Singleton; David J Stone; Rita Guerreiro; Jose Bras
Journal:  Neurobiol Aging       Date:  2018-10-24       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.